Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotonin Modulation of Prefronto-Hippocampal Rhythms in Health and Disease
M. Victoria Puig, Thomas Gener
ACS Chemical Neuroscience (2015) Vol. 6, Iss. 7, pp. 1017-1025
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

The serotonergic system and cognitive function
Dubravka Švob Štrac, Nela Pivac, Dorotea Mück‐Šeler
Translational Neuroscience (2016) Vol. 7, Iss. 1, pp. 35-49
Open Access | Times Cited: 239
Serotonin, Amygdala and Fear: Assembling the Puzzle
Marco Bocchio, Stephen B. McHugh, David M. Bannerman, et al.
Frontiers in Neural Circuits (2016) Vol. 10
Open Access | Times Cited: 177
Theranostic Biomarkers for Schizophrenia
Matea Nikolac Perković, Gordana Nedić Erjavec, Dubravka Švob Štrac, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 4, pp. 733-733
Open Access | Times Cited: 98
Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia
Alireza Mohammadi, Ehsan Rashidi, Vahid Ghasem Amooeian
Psychiatry Research (2018) Vol. 265, pp. 25-38
Closed Access | Times Cited: 92
Neuromodulation of Hippocampal-Prefrontal Cortical Synaptic Plasticity and Functional Connectivity: Implications for Neuropsychiatric Disorders
Rafael Naime Ruggiero, Matheus Teixeira Rossignoli, Danilo Benette Marques, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 61
Converging models of schizophrenia – Network alterations of prefrontal cortex underlying cognitive impairments
Takeshi Sakurai, Nao J. Gamo, Takatoshi Hikida, et al.
Progress in Neurobiology (2015) Vol. 134, pp. 178-201
Open Access | Times Cited: 80
On the Physiological Modulation and Potential Mechanisms Underlying Parieto-Occipital Alpha Oscillations
Diego Lozano‐Soldevilla
Frontiers in Computational Neuroscience (2018) Vol. 12
Open Access | Times Cited: 68
Prefrontal–hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability
Maria Alemany-González, Thomas Gener, Pau Nebot, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 21, pp. 11788-11798
Open Access | Times Cited: 57
Neural mechanisms underlying psilocybin’s therapeutic potential – the need for preclinical in vivo electrophysiology
Rebecca Smausz, Joanna C. Neill, John Gigg
Journal of Psychopharmacology (2022) Vol. 36, Iss. 7, pp. 781-793
Open Access | Times Cited: 33
Screening the effective components of Suanzaoren decoction on the treatment of chronic restraint stress induced anxiety-like mice by integrated chinmedomics and network pharmacology
Yan Yan, Jiahan Li, Yinjie Zhang, et al.
Phytomedicine (2023) Vol. 115, pp. 154853-154853
Closed Access | Times Cited: 16
It’s All in the Rhythm: The Role of Cannabinoids in Neural Oscillations and Psychosis
Patrick D. Skosnik, Jose Cortes-Briones, Mihály Hajós
Biological Psychiatry (2015) Vol. 79, Iss. 7, pp. 568-577
Closed Access | Times Cited: 63
Neural Substrates of Psychosis and Cognitive Impairment in Mouse Models of Schizophrenia
M. Victoria Puig, Thomas Gener, Cristina López-Cabezón and Sara Hidalgo-Nieves
IntechOpen eBooks (2025)
Closed Access
The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors
Maurizio S. Riga, Laia Lladó-Pelfort, Francesc Artigas, et al.
Neuropharmacology (2017) Vol. 142, pp. 219-230
Open Access | Times Cited: 48
Assessment of Cognition in Schizophrenia Using Trail Making Test: A Meta-Analysis
Erna Laere, Shiau Foon Tee, Pek Yee Tang
Psychiatry Investigation (2018) Vol. 15, Iss. 10, pp. 945-955
Open Access | Times Cited: 44
Prediction of Learned Resistance or Helplessness by Hippocampal-Prefrontal Cortical Network Activity during Stress
Danilo Benette Marques, Rafael Naime Ruggiero, Lézio Soares Bueno-Júnior, et al.
Journal of Neuroscience (2021) Vol. 42, Iss. 1, pp. 81-96
Open Access | Times Cited: 27
Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors
Jaqueline Maisa Franzen, Isabel Werle, Felipe Vanz, et al.
Neuropharmacology (2022) Vol. 223, pp. 109316-109316
Closed Access | Times Cited: 19
Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility
Qi Zhong, Xiangdong Chen, Yan Zhao, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Degeneration of serotonin neurons triggers spasticity in amyotrophic lateral sclerosis
Hajer El Oussini, Jelena Scekic‐Zahirovic, Pauline Vercruysse, et al.
Annals of Neurology (2017) Vol. 82, Iss. 3, pp. 444-456
Closed Access | Times Cited: 34
Serotonin 5-HT1A, 5-HT2A and dopamine D2 receptors strongly influence prefronto-hippocampal neural networks in alert mice: Contribution to the actions of risperidone
Thomas Gener, Adrià Tauste Campo, Maria Alemany-González, et al.
Neuropharmacology (2019) Vol. 158, pp. 107743-107743
Open Access | Times Cited: 32
Hippocampal Interaction With Area 25, but not Area 32, Regulates Marmoset Approach–Avoidance Behavior
Chloe U. Wallis, Gemma J. Cockcroft, Rudolf N. Cardinal, et al.
Cerebral Cortex (2019) Vol. 29, Iss. 11, pp. 4818-4830
Open Access | Times Cited: 31
Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder
Andrew F. Leuchter, Aimee M. Hunter, Felipe A. Jain, et al.
Journal of Psychiatric Research (2016) Vol. 84, pp. 174-183
Closed Access | Times Cited: 27
Effects of Dopamine and Serotonin Systems on Modulating Neural Oscillations in Hippocampus-Prefrontal Cortex Pathway in Rats
Xiaxia Xu, Chenguang Zheng, Lei An, et al.
Brain Topography (2016) Vol. 29, Iss. 4, pp. 539-551
Closed Access | Times Cited: 26
Schizophrenia in the genetic era: a review from development history, clinical features and genomic research approaches to insights of susceptibility genes
Ye Lv, Lin Wen, Wen-Juan Hu, et al.
Metabolic Brain Disease (2023) Vol. 39, Iss. 1, pp. 147-171
Closed Access | Times Cited: 7
Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer’s disease
Ali Azargoonjahromi
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: Effects of antipsychotic drugs and receptor ligands
Laia Lladó-Pelfort, Eva Troyano-Rodriguez, Hanna E. van den Munkhof, et al.
European Neuropsychopharmacology (2015) Vol. 26, Iss. 3, pp. 614-625
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top